mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |